Recent Updates
Recently added Catalysts
LNTH Negative Sentiment

LANTHEUS HOLDINGS, INC. (NASDAQ: LNTH) DEADLINE ALERT Bernstein Liebhard LLP Reminds Lantheus Holdings, Inc. Investors of Upcoming Deadline

Key Takeaway: Bernstein Liebhard LLP is reminding investors of Lantheus Holdings, Inc. about an upcoming deadline regarding a securities fraud class action lawsuit. This case concerns accusations that the company misrepresented the competitive position of its oncology product, Pylarify. Investors who purchased shares between February 26, 2025, and August 5, 2025, may be eligible to participate in the lawsuit, with a filing deadline of November 10, 2025. The law firm operates on a contingency fee basis, meaning shareholders will not incur fees unless they win the case.
Price reaction · baseline $56.06 (2025-10-24 close) · 5 other LNTH headline(s) in the window, move may be shared
day 0 close · peak
+3.7%

Market Sentiment Analysis

CONCERNS & RISKS

  • Investors are reminded of a deadline concerning a securities fraud class action lawsuit against Lantheus.
  • The lawsuit indicates that the company made misrepresentations about its key product, Pylarify.
  • The timeline for the lawsuit involves a specific period where investors may have lost money.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
Do you, or did you, own shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)?
Did you purchase your shares between February 26, 2025 and August 5, 2025, inclusive?
Did you lose money in your investment in Lantheus Holdings, Inc.?
Do you want to discuss your rights?
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
If you purchased or acquired Lantheus securities, and/or would like to discuss your legal rights and options please visit Lantheus Holdings, Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com.
A lawsuit was filed in the United States District Court for the Southern District of New York on behalf of investors who purchased or acquired the securities of Lantheus between February 26, 2025 and August 5, 2025, inclusive.
According to the lawsuit, Defendants made misrepresentations concerning the competitive position of the Company’s key Radiopharmaceutical Oncology product, Pylarify.
If you wish to serve as lead plaintiff for the Class, you must file papers by November 10, 2025. A lead plaintiff is a representative party acting on other class members’ behalf in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years.
ATTORNEY ADVERTISING. © 2025 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Investor Relations Manager
Bernstein Liebhard LLP

Frequently Asked Questions

Who can participate in the Lantheus class action lawsuit?

Investors who purchased Lantheus shares between February 26 and August 5, 2025, can participate.

What is the deadline to file for lead plaintiff in the lawsuit?

The deadline to file for lead plaintiff status is November 10, 2025.

Do shareholders have to pay fees for legal representation?

No, all representation is on a contingency fee basis, incurring no costs for shareholders.

What does the lawsuit allege about Lantheus Holdings?

The lawsuit claims misrepresentations regarding the competitive position of Pylarify.

Where can I find more information about the lawsuit?

Visit the Lantheus Holdings, Inc. Shareholder Class Action Lawsuit webpage for details.

Last updated: Oct 27, 2025